25 Workshop attendees from NDM and Isis Innovation from Oxford (via skype), ITESM Campus Cd de Mexico, BUAP, UMSNH, LESPM as well as state and municipal health authorities of Quintana Roo, discussed follow-up progress of the dengue vaccine development, as well as the Epidemiological Surveillance carried out in the Mexican states of Quintana Roo and Michoacan. Questions of Technology Transfer and Commercialisation of IP were also addressed by Isis Innovation (Oxford) and the ITESM’s Technology Transfer Office representatives.
This pilot project emerged as a part of the efforts of the Reyes-Sandoval group to develop a novel dengue vaccine. Various parallel projects including in vivo preclinical work with other international collaborators are ongoing, and the pilot project currently taking place in human cohorts in Mexico is part of the efforts to understand the potential immunogenicity of the experimental vaccine ex vivo. The data generated from this project will serve as preliminary data for future funding calls including those part of the Newton Fund.
It should be noted this research and techniques used on the isolation and preservation of peripheral blood mononuclear cells for analysis of antigen-reactive T-cell responses for this research is the successful outcome of the first NDM-Mexico 2-week long training workshop of Mexican scientists and students held at the NDM labs during the summer.
Thank you to all the participants for contributing to making this a highly successful workshop!